is the Senior Vice President, Molecular Business Unit at QuidelOrtho, a position she has held since September 2020. Ranalli first joined Quidel in 2010 and has had various roles leading molecular program management, R&D, and marketing. She earned a PhD in biochemistry from the University of Rochester School of Medicine and Dentistry and postdoctoral training in cancer genetics at Roswell Park Cancer Institute.